The clinical use of which of the following drug is stopped because of severe bronchospasm associated with it-
Rapacuronium is an aminosteroid compound that was introduced for clinical use in the limited states in 1999 and was withdrawn in 2001 because of rare, but severe, cases of bronchospasm.
Rapacuronium
Rocuronium
Atracurium
Mivacurium
Neuromuscular Blocker